Home › Alpha-1 Antitrypsin Deficiency

Alpha-1 Antitrypsin Deficiency clinical trials recruiting in the U.S.

14 studies for Alpha-1 Antitrypsin Deficiency are recruiting participants at sites across the United States.

Alpha-1 Antitrypsin Deficiency is an inherited condition that raises your risk for lung and liver disease. Learn about the symptoms and treatment.

Cities with the most studies

• Charleston, SC6 studies
• Gainesville, FL6 studies
• Birmingham, AL5 studies
• Boston, MA4 studies
• Rochester, MN4 studies
• New York City, NY4 studies
• Cleveland, OH3 studies
• Los Angeles, CA3 studies
• Phoenix, AZ3 studies
• Miami, FL3 studies

By state

• Alabama5 studies
• Arizona3 studies
• California4 studies
• Colorado3 studies
• Florida9 studies
• Massachusetts4 studies
• Minnesota4 studies
• New York4 studies
• Ohio3 studies
• South Carolina6 studies
• Texas4 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.